CD44 and neoplasm: In addition, transcription factors known as tumor suppressors or genes related to breast cancer including c-FOS, EGR1, ID2 and SERPINB2, as well as suppression of metastasis associated genes (CD44 and IL11) have emerged as molecular targets of BSP knockdown.